Xcellerant Ventures
  • Portfolio
  • Team
  • About
  • Invest
  • News
  • Contact
Select Page
TruLite Health Selected for Microsoft Pegasus Program

TruLite Health Selected for Microsoft Pegasus Program

by Xcellerant Ventures | Oct 3, 2024 | Portfolio Company News

Origionally posted on TruLite Health website: https://trulitehealth.com/trulite-health-selected-for-microsoft-for-startups-pegasus-program/ TEMPE, ARIZ. (October 03, 2024) – TruLite Health, developer of the only health equity solution to remediate clinical bias, is...
Xcellerant Ventures Leads DeepLook Medical’s Series A Round

Xcellerant Ventures Leads DeepLook Medical’s Series A Round

by Xcellerant Ventures | Sep 24, 2024 | Portfolio Company News, Xcellerant Ventures News

Origionally posted on Business Wire: https://www.businesswire.com/news/home/20240924360690/en/Xcellerant-Ventures-Leads-DeepLook-Medical%E2%80%99s-Series-A-Round   SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Xcellerant Ventures is proud to announce that it will lead...
DeepLook Medical’s DL Precise™ improved the performance of the breast imaging department with 12% favorable change in recall rates

DeepLook Medical’s DL Precise™ improved the performance of the breast imaging department with 12% favorable change in recall rates

by Xcellerant Ventures | Sep 17, 2024 | Portfolio Company News

Origionally posted on DeepLook Medical’s Website: https://www.deeplookmedical.com/post/deeplook-medical-s-dl-precise-improved-the-performance-of-the-breast-imaging-department-with-12-fa   Finding cancer in a mammogram is difficult, especially with women who...
DeepLook Medical Secures 2nd Patent

DeepLook Medical Secures 2nd Patent

by Xcellerant Ventures | Apr 19, 2024 | Portfolio Company News

Origionally posted on DeepLook Medical’s Website: https://www.deeplookmedical.com/post/deeplook-medical-secures-2nd-patent     On April 16, 2024 DeepLook Medical was issued their second patent...
UK Regulatory Approval for DL Precise™ Software

UK Regulatory Approval for DL Precise™ Software

by Xcellerant Ventures | Mar 5, 2024 | Portfolio Company News

Origionally posted on DeepLook Medical’s website: https://www.deeplookmedical.com/post/deeplook-medical-s-dl-precise-software-secures-regulatory-approval-in-the-uk   New Haven, CT – March 6,  2024: DeepLook Medical, a Connecticut-based technology firm,...
« Older Entries

Recent Posts

  • TruLite Health Partners with Lee Health to Elevate Health Equity Strategy
  • TruLite Health Selected for Microsoft Pegasus Program
  • Xcellerant Ventures Leads DeepLook Medical’s Series A Round
  • DeepLook Medical’s DL Precise™ improved the performance of the breast imaging department with 12% favorable change in recall rates
  • Feasibility Study Evaluates Potential of Digital Health Platform to Help Patients Manage Prostate Cancer Symptoms

Recent Comments

No comments to show.
  • Portfolio
  • Team
  • About
  • Invest
  • News
  • Contact
  • Privacy Policy
© Xcellerant Ventures 2023